Table 1

Baseline characteristics of the population

Total
(N=442)
Placebo
(N=222)
Metoprolol (N=220)P value
Patient demographics
Age (years)62.5±11.662.9±11.862±11.40.41
Male sex331/442 (74.89%)162/222 (72.97%)169/220 (76.82%)0.38
Prior MI17/440 (3.86%)8/221 (3.62%)9/219 (4.11%)0.81
Prior PCI29/441 (6.58%)12/221 (5.43%)17/220 (7.73%)0.34
Prior CVA11/4441 (2.48%)4/221 (1.81%)7/220 (3.18%)0.38
Renal failure8/436 (1.83%)5/218 (2.29%)3/218 (1.38%)0.72
Peripheral VD8/441 (1.81%)5/221 (2.26%)3/220 (1.36%)0.72
Risk factors
Smoking175/409 (42.79%)90/202 (44.55%)85/207 (41.06%)0.48
Family history163/391 (41.69%)82/192 (42.71%)81/199 (40.07%)0.75
Hypertension170/440 (38.64%)84/220 (38.18%)86/220 (39.09%)0.92
Hypercholesterolaemia108/433 (24.94%)52/217 (23.96%)56/216 (25.93%)0.65
Diabetes mellitus67/442 (15.16%)38/222 (17.12%)29/220 (13.18%)0.28
Infarct location0.21
Anterior173/384 (45.05%)95/194 (48.97%)78/190 (41.05%)
Inferior174/384 (45.31%)77/194 (39.69%)97/190 (51.05%)
Lateral27/384 (7.03%)16/194 (8.25%)11/190 (5.79%)
Posterior6/384 (1.56%)4/194 (2.06%)2/190 (1.05%)
Unknown4/384 (1.04%)2/194 (1.03%)2/190 (1.05%)
Heart frequency78.2 (18.1)77.8 (18.6)78.6 (17.7)0.67
Rhythm0.25
SR386/409 (94.38%)193/203 (95.07%)193/206 (93.69%)
AF19/409 (4.65%)8/203 (3.94%)11/206 (5.34%)
Other2/409 (0.49%)0/2032/206 (0.97%)
ST deviation >3mm357/369 (96.75%)180/184 (97.83%)177/185 (95.68%)0.38
Categories of ST deviation0.42
Normalised ST segment8/369 (2.17%)3/184 (1.63%)5/185 (2.7%)
1–3 mm deviation4/369 (1.08%)1/184 (0.54%)3/185 (1.62%)
4–6 mm deviation30/369 (8.13%)12/184 (6.52%)18/185 (9.73%)
>6 mm deviation327/369 (88.62%)168/184 (91.3%)159/185 (85.95%)
  • Data are n/N (%) or mean (±SD).

  • .AF, atrial fibrillation; CVA, cerebral vascular accident; MI, myocardial infarction; PCI, percutaneous coronary intervention; SR, sinus rhythm; VD, vascular disease.;